Leading a team of procurement professionalsCountries in scope: Czech, Hungary, Romania, Slovakia, Slovenia and other Balkan markets

Kicked off and led standardized forecast and planning meetings organized for top management, mitigating probability of out of stock situations, contributed to continuous improvement of the process within the CEE region Successfully managed budget preparation of SG&A and encouraged more accurate cost allocation across the company through discussion with team managers and accountantsResponsible for plan submission including sales projection, profit release, net costs and transfer prices revision, generating credibility and clearness for commercial teams Challenged and reviewed expenses and its structure for business cost centers, identifying new opportunities on return on investment and how to measure benefits of campaigns Actively participated in month end closing procedures – accruals calculation, sales reviewsSupervised and exposed junior colleagues to diverse finance tasks and projects Served as finance partner for business teams, providing guidance through financial data and business cases

Coordinated planning activities across various therapeutic areas with European Supply Chain Managers, improved forecast accuracy by 35% in case of major brands and communicated business impact to LOC teams Run a scenario analysis aimed at performance of discounted brands and proposed gross to net optimization in line with competition law, subsequently increasing profitability by 20% Delivered a financial model for the Mid-Month Estimate eliminating 2/3rds of major discrepancies and regularly reported its results to headquarters and CE Cluster Promoted company’s attractiveness among students and graduates as a role model in GSK Recruitment Video

Department of ManagementResearch project involved: Organizational Trauma

Responsible for doing sales analysis and portfolio optimizationHelping to implement bonus structure for hospital portfolio in cooperation with EP LeadEvaluating financial performance of key molecules in comparison with market and ATC groups